cefiderocol (Fetroja) Report issue

Small molecule Approved FDA Fast Track FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Cefiderocol, sold under the brand name Fetroja among others, is an antibiotic used to treat complicated urinary tract infections when no other options are available. It is indicated for the treatment of multi-drug-resistant Gram-negative bacteria including Pseudomonas aeruginosa. It is given by injection into a vein.   Wikipedia

Chemistry

  • SMILES: CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[N+]4(CCNC(=O)C3=C(Cl)C(O)=C(O)C=C3)CCCC4)=C(N2C1=O)C([O-])=O)C5=CSC(N)=N5)C(O)=O
  • InChIKey: DBPPRLRVDVJOCL-FQRUVTKNSA-N
  • Mol. Mass: 752.215
  • ALogP: Missing data
  • ChEMBL Molecules: Missing data
More Chemistry

Pharmacology

Drug Pricing (per unit)

United States

$137.2320 - $176.9580
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Organizations (8)

Research & Development (8)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (8)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (8)


 

Abdominal Injuries (Phase 2)

Blood-Borne Infections (Phase 2)

Gram-Negative Bacterial Infections (Phase 2)

Healthcare-Associated Pneumonia (Phase 2)

Pneumonia, Bacterial (Phase 1)

Pneumonia, Ventilator-Associated (Phase 2)

Sepsis (Phase 2)

Urinary Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial Organizations: 8

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue